Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Lidocaine for Hemodynamic Response to Intubation
NCT03612492Phase 4Unknown
- Sponsor
- Hospital de Base de São José do Rio Preto
- Start
- Jul 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esmolol in hemodynamic instability (2 arms), sponsored by Hospital de Base de São José do Rio Preto. Primary endpoint: Number of participants with tachycardia after intubation at 12 minutes. Status: unknown.
02
Drugs
esmolol
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT03612492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03612492.